🕒 Last update: loading…

Stock Zoetis Inc. ZTS

Zoetis Inc. — Investlytic score 2/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met. Data as of 03/10/2026.

  • ❌ Price trend failed
  • ✅ Growth passed
  • ❌ Debt failed
  • ✅ P/E passed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 54.72%

Price change 2019 → 2020: 25.05%

Price change 2020 → 2021: 47.45%

Price change 2021 → 2022: -39.95%

Price change 2022 → 2023: 34.68%

Price change 2023 → 2024: -17.45%

Price change 2024 → 2025: -22.78%

Price change 2025 → 2026: -45.08%

Price change 2026 (year to date): -45.12%

Financial growth

Revenue CAGR (8 years): 7.18%

Earnings CAGR (8 years): 9.37%

Growth status: positive trend (>1%/yr) in revenue and earnings.

Debt

Debt-to-equity ratio: 2.85

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 10.59

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 43.69% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, mechanical verdict of the method (hold, watch, sell: the same for all) and the detail of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Zoetis Inc.12.72.85+6.7 %🔒
ResMed Inc.20.80.14+10.8 %★ 4/5
Fresenius SE & Co. KGaA17.70.62+2.4 %–
Illumina, Inc.41.20.94+11.0 %–
Genmab A/S40.60.95+28.9 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Zoetis Inc. over the latest fiscal years.

Revenue
9.5 bn USD
fiscal year 2025
Net income
2.7 bn USD
fiscal year 2025
Net margin
28.2 %
fiscal year 2025
Average annual growth
+7.2 %
Revenue growth over 5 years
Average annual growth
+7.1 %
Revenue growth over 10 years
Market cap
34.1 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
20206.7 bn1.6 bn24.5 %n/a
20217.8 bn2.0 bn26.2 %+16.5 %
20228.1 bn2.1 bn26.2 %+3.9 %
20238.5 bn2.3 bn27.4 %+5.7 %
20249.3 bn2.5 bn26.9 %+8.3 %
20259.5 bn2.7 bn28.2 %+2.3 %

Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Zoetis Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
average accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
4.78
safe zone (above 2.99)
Piotroski Score
6 / 9
4 to 6: average accounts
DCF Value
173.13 USD
DCF above share price · share price 83.04 USD, gap +108.5 %
Net Debt / EBITDA
2.06 x
moderate debt
Fiscal year20212022202320242025
Cash and investments3.5 bn3.6 bn2.0 bn2.0 bn2.3 bn
Total Debt6.7 bn8.1 bn6.8 bn6.7 bn9.5 bn
Net Debt3.3 bn4.5 bn4.7 bn4.8 bn7.2 bn
Equity4.5 bn4.4 bn5.0 bn4.8 bn3.3 bn
Total assets13.9 bn14.9 bn14.3 bn14.2 bn15.5 bn
Operating cash flow2.2 bn1.9 bn2.4 bn3.0 bn2.9 bn
Investments (capex)477 m586 m732 m655 m621 m
Free cash-flow1.7 bn1.3 bn1.6 bn2.3 bn2.3 bn
Share buybacks743 m1.6 bn1.1 bn1.9 bn3.2 bn
Dividends paid474 m611 m692 m786 m889 m

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)14.09 x
Price / book value10.34 x
Return on Equity (ROE)76.4 %
Return on Invested Capital (ROIC)20.9 %
Net margin26.1 %
Debt / equity2.80 x
Current ratio2.35 x
Interest coverage14.25 x
Free cash-flow yield6.8 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.

+

Valuation and competitors

Zoetis Inc. compared with its sector on the same exchange and with its main competitors.

Company P/E
12.7
54.0 % below the sector
Sector median P/E
27.7
healthcare, NYSE
Sector over 10 years
22.3
10-year median, range 18.4 to 44.9

Direct competitors

CompanyMarket cap (USD)P/ENet margin
Zoetis Inc.32.8 bn12.128.2 %
Elanco Animal Health Incorporated ELAN12.9 bn24.3-4.9 %
IDEXX Laboratories, Inc. IDXX53.3 bn47.524.6 %
Neogen Corporation NEOG2.6 bn42.0-122.1 %
Phibro Animal Health Corporation PAHC1.3 bn11.23.7 %
Merck & Co., Inc. MRK362 bn45.728.1 %
Sector median (NYSE)27.7

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 13/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Zoetis Inc. publish: ratings, price targets and earnings forecasts.

Majority rating
hold
32 analysts
Average price target
84.75 USD
from 74.00 USD to 95.00 USD, 22 targets over 12 months
Gap with the share price
+6.7 %
price 79.40 USD on 06/11/2026

Breakdown of ratings

strong buy 1buy 13hold 18sell 0strong sell 0

Analysts' average target 84.75 USD, DCF value 173.13 USD, share price 79.40 USD.

Average target over the last 3 months: 82.60 USD (5 targets).

Analyst forecasts

Fiscal yearRevenueNet incomeExpected EPS (range)P/E on this EPSAnalysts
20269.3 bn2.6 bn6.21 (5.73 / 6.31)12.89
20279.3 bn2.8 bn6.34 (5.99 / 6.78)12.510
20289.7 bn2.7 bn6.76 (5.57 / 8.00)11.77

Amounts in USD, the reporting currency.

Track record against expectations: reported EPS above consensus 10 times over the last 12 releases.

Rating changes (12 months)

DateFirmBeforeAfter
29/10/2026Morgan StanleyOverweightOverweight
27/10/2026UBSNeutralNeutral
20/10/2026JefferiesBuyHold
25/08/2026TD CowenBuyBuy
20/08/2026StifelHoldHold

Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.

+

Dividends and earnings

Zoetis Inc.: dividend history, last distributions, stock splits and earnings releases.

Frequency
quarterly
Last dividend
0.530 USD
ex-dividend on 30/10/2026
Last 12 months
2.12 USD
number of payments: 4
Yield
1.6 %
on the last known price
Years of increases
13
consecutive
Years of payments
13
uninterrupted
00.531.061.592.122013 : 0.195 USD2014 : 0.288 USD20142015 : 0.332 USD2016 : 0.380 USD20162017 : 0.420 USD2018 : 0.504 USD20182019 : 0.656 USD2020 : 0.800 USD20202021 : 1.00 USD2022 : 1.30 USD20222023 : 1.50 USD2024 : 1.73 USD20242025 : 2.00 USD2026 : 2.12 USD2026

Annual dividend per share (USD), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.

Latest ex-dividend dates

Ex-dividendAmountPayment
30/10/20260.530 USD01/12/2026
20/07/20260.530 USD01/09/2026
20/04/20260.530 USD02/06/2026
20/01/20260.530 USD03/03/2026
31/10/20250.500 USD02/12/2025
18/07/20250.500 USD03/09/2025
21/04/20250.500 USD03/06/2025
21/01/20250.500 USD04/03/2025

Earnings releases

DatePublished EPSExpected EPSSurprise
05/11/20261.751.51+15.9 %
06/08/20261.871.85+1.1 %
07/05/20261.531.60-4.4 %
12/02/20261.481.40+5.7 %
04/11/20251.701.62+4.9 %
05/08/20251.761.62+8.6 %

Factual data: ex-dividend history and earnings calendar, as of 15/11/2026. A past dividend does not guarantee the next one.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Zoetis Inc.

Free float
99.8 %
share of freely traded shares
Large funds tracked
31
hold the stock as of 2026Q2
US elected officials
23
13 purchases, 10 sales in 12 months

Indices: S&P 500 (since 21/06/2013).

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
Vanguard Group47.8 m6.0 bn0.1 %+12.9 %2025Q4
BlackRock39.4 m2.8 bn0.0 %+10.8 %2026Q2
State Street39.3 m2.8 bn0.0 %+103.6 %2026Q2
Geode Capital Management13.3 m952 m0.1 %+17.1 %2026Q2
Wellington Management9.4 m677 m0.1 %-7.2 %2026Q2
Morgan Stanley8.9 m638 m0.0 %-37.2 %2026Q2
Citadel Advisors6.4 m458 m0.1 %+1,172.7 %2026Q2
Northern Trust5.5 m398 m0.1 %-0.1 %2026Q2

Elected officials' disclosures

DateOfficialSideAmount
13/10/2026Ro Khannapurchase$1,001 - $15,000
07/10/2026Ro Khannasale$1,001 - $15,000
21/10/2026Shelley Moore Capitosale$1,001 - $15,000
21/10/2026Shelley Moore Capitosale$1,001 - $15,000
18/09/2026Gilbert Cisnerospurchase$1,001 - $15,000

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE
IPO: 01/02/2013
ISIN code
US98978V1035
Workforce
13,800
full-time employees
Chief executive
Kristin C. Peck
Next earnings
11/02/2027

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Zoetis Inc.

What is the Zoetis Inc. share price?

Latest recorded price: 83.82 USD on 13/11/2026, for a market cap of 34.1 bn USD.

What is the revenue of Zoetis Inc.?

9.5 bn USD for fiscal year 2025, with net income of 2.7 bn USD (net margin 28.2 %).

Does Zoetis Inc. pay a dividend?

Yes. Latest dividend: 0.530 USD per share, ex-dividend on 30/10/2026. Over 12 months: 2.12 USD. Yield on the latest known price: 1.6 %.

When does Zoetis Inc. report its next earnings?

The next release is expected on 11/02/2027. EPS expected by analysts: 1.22.

What do analysts say about Zoetis Inc.?

Out of 32 analysts: 14 buy or strong buy, 18 hold, 0 sell or strong sell. Average price target: 84.75 USD, i.e. +6.7 % from the share price.

What is the P/E ratio of Zoetis Inc.?

Trailing 12-month P/E of 12.7, against 27.7 for the sector median on the same exchange (10-year median: 22.3).

Is Zoetis Inc. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US98978V1035).

How many employees does Zoetis Inc. have?

13,800 full-time employees according to the latest published profile.

Who runs Zoetis Inc.?

Kristin C. Peck is the company's chief executive.

Which large funds own Zoetis Inc.?

As of 2026Q2, among the large funds tracked: Vanguard Group, BlackRock, State Street, Geode Capital Management, Wellington Management.

07

Similar stocks